Drug Tracking Talks Continue As Panel OKs FDA Fee Bill
A House panel on Thursday unanimously approved legislation authorizing the U.S. Food and Drug Administration's $2.8 billion user fee agreements, setting the bill up for a floor vote by the end...To view the full article, register now.
Already a subscriber? Click here to view full article